These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 31085817)
1. A volatile biomarker in breath predicts lung cancer and pulmonary nodules. Phillips M; Bauer TL; Pass HI J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817 [TBL] [Abstract][Full Text] [Related]
2. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening. Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306 [TBL] [Abstract][Full Text] [Related]
3. Breath carbonyl compounds as biomarkers of lung cancer. Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567 [TBL] [Abstract][Full Text] [Related]
4. A novel technology to integrate imaging and clinical markers for non-invasive diagnosis of lung cancer. Shaffie A; Soliman A; Fu XA; Nantz M; Giridharan G; van Berkel V; Khalifeh HA; Ghazal M; Elmaghraby A; El-Baz A Sci Rep; 2021 Feb; 11(1):4597. PubMed ID: 33633213 [TBL] [Abstract][Full Text] [Related]
5. Rapid point-of-care breath test predicts breast cancer and abnormal mammograms in symptomatic women. Phillips M; Bevers TB; Larsen LH; Pappas N; Pathak S J Breath Res; 2024 Sep; 18(4):. PubMed ID: 39265580 [TBL] [Abstract][Full Text] [Related]
6. Prediction of breast cancer risk with volatile biomarkers in breath. Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019 [TBL] [Abstract][Full Text] [Related]
7. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer. Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249 [TBL] [Abstract][Full Text] [Related]
8. Detection of lung cancer with volatile markers in the breath. Phillips M; Cataneo RN; Cummin AR; Gagliardi AJ; Gleeson K; Greenberg J; Maxfield RA; Rom WN Chest; 2003 Jun; 123(6):2115-23. PubMed ID: 12796197 [TBL] [Abstract][Full Text] [Related]
9. Prediction of lung cancer using volatile biomarkers in breath. Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Greenberg J; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P Cancer Biomark; 2007; 3(2):95-109. PubMed ID: 17522431 [TBL] [Abstract][Full Text] [Related]
10. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study. Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569 [TBL] [Abstract][Full Text] [Related]
11. Detection of volatile biomarkers of therapeutic radiation in breath. Phillips M; Byrnes R; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mehta V; Mundada M; Patel U; Ramakrishna N; Schiff PB; Zhang X J Breath Res; 2013 Sep; 7(3):036002. PubMed ID: 23793046 [TBL] [Abstract][Full Text] [Related]
13. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath. Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415 [TBL] [Abstract][Full Text] [Related]
14. Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma. Li X; Shi L; Long Y; Wang C; Qian C; Li W; Tian Y; Duan Y J Breath Res; 2024 Aug; 18(4):. PubMed ID: 39019071 [TBL] [Abstract][Full Text] [Related]
15. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study. Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453 [TBL] [Abstract][Full Text] [Related]
16. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642 [TBL] [Abstract][Full Text] [Related]
17. Progress in the development of volatile exhaled breath signatures of lung cancer. Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541 [TBL] [Abstract][Full Text] [Related]
18. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557 [TBL] [Abstract][Full Text] [Related]
19. Detection of lung cancer using weighted digital analysis of breath biomarkers. Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P; Wai J Clin Chim Acta; 2008 Jul; 393(2):76-84. PubMed ID: 18420034 [TBL] [Abstract][Full Text] [Related]
20. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]